Showing 211 - 220 of 21,528
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012141882
We show that when the researcher’s (observable but not contractible) contribution to innovation is crucial, a covenant not to compete (CNC) reduces e.ort and profits under both spot and relational contracts. Having no CNC allows the researcher to leave for a rival. This alleviates a commitment...
Persistent link: https://www.econbiz.de/10012142258
Economic interest in innovation policy largely arises from the fundamental importance of innovation to social welfare and from inefficiencies in innovation in a competitive market environment. As a result, a wide variety of public innovation policies are used in practice. This study reviews the...
Persistent link: https://www.econbiz.de/10012148172
We investigate the impacts of improved intellectual property rights (IPR) protection on cross-border M&A performance. Using multiple measures of IPR protection and based on generalized difference-in-differences estimates, we find that countries with better IPR protection attract significantly...
Persistent link: https://www.econbiz.de/10012148319
This work investigates the relationship between proxies of innovation activities, such as patents and trademarks, and firm performance in terms of revenues and growth. By resorting to the virtual universe of Italian manufacturing firms we provide a rather complete picture of the innovation...
Persistent link: https://www.econbiz.de/10012157009
This paper explores how regulatory responses to emerging IP issues in digital trade may develop at the international level and in particular how existing mechanisms might influence the chances of developing internationally agreed rules in this regard. The primacy of state sovereignty in...
Persistent link: https://www.econbiz.de/10012431210
The UK’s business R&D (BERD) to GDP ratio is low compared to other leading economies,and the ratio has slowly declined over the 1990s. This paper uses data on large UK firms toanalyse the link between R&D and productivity over the 1989-2000 period. Using aproduction function approach, and a...
Persistent link: https://www.econbiz.de/10005870179
This paper analyses market valuations of UK companies using a new data set of their R&Dand IP activities (1989-1999). In contrast to previous studies, the analysis is conducted at thesectoral level, where the sectors are based on the technological classification in Pavitt (1984).The first main...
Persistent link: https://www.econbiz.de/10005870214
Compulsory licensing allows firms in developing countries to produce foreign-owned inventions withoutthe consent of foreign patent owners. This paper uses an exogenous event of compulsory licensingafter World War I under the Trading with the Enemy Act to examine the long run effects of...
Persistent link: https://www.econbiz.de/10005870416
The increasing commercialization of university discoveries has initiated acontroversy on the impacts for future scientific research. It has been argued that anincreasing orientation towards commercialization may have a negative impact onmore fundamental research efforts in science. Several...
Persistent link: https://www.econbiz.de/10008939750